Biden-Harris Administration moves on affordable and accessible healthcare

27 October 2022
hhsbig

In the USA, the Biden-Harris Administration has made expanding access to health insurance and lowering health care costs for America’s families a top priority, and, starting now, consumers can preview their health care coverage options and see the savings available to them in the most competitive Marketplace in history.

Consumers can now visit HealthCare.gov to view detailed information about 2023 health insurance plans and prices offered in their area in advance of the 2023 Marketplace Open Enrollment period that begins November 1, 2022.

Under the Biden-Harris Administration, the national uninsured rate has reached an all-time low, and more Americans than ever before have health insurance through the Marketplace. As we begin the 10th Open Enrollment period, the Marketplace is stronger than ever – with continuing record affordability, robust competition, and unprecedented outreach efforts.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical